Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury
NCT: NCT06467708 · RECRUITING
Brief Summary
The overarching goal of this pilot study is to assess the feasibility and safety of transcutaneous auricular neurostimulation (tan) in ICU patients with TBi and to determine the effect of tan on serum markers of inflammation. exploratory analyses will examine effects on such physiological parameters as blood pressure, heart rate, and intracranial pressure (iCP), as well as measures of neurological function.
Frequently Asked Questions
What is Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury?
Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury is a clinical trial registered under NCT06467708. Current status: RECRUITING.
What is the status of NCT06467708?
The current status of NCT06467708 (Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury) is: RECRUITING.
When did Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury start?
Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury started on 2025-02-11.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.